Innovative Biopharma Focus InVitria specializes in developing scalable and sustainable recombinant products for advanced cell and gene therapies, vaccines, and regenerative medicines, presenting opportunities to supply tailored reactants and media for cutting-edge biopharma companies.

Recent Product Launches The launch of OptiLeukin 2, a chemically defined, animal- and bacteria-free recombinant IL-2, showcases their capacity for creating specialized bioproducts, which can be leveraged to meet growing demand for high-purity cell manufacturing reagents.

Expansion & Global Presence Expanding facilities in Munich and offering local supply options in the UK suggest InVitria’s commitment to regional service, opening channels for partnerships with international biopharma firms seeking reliable, on-demand manufacturing supplies.

Partnership Expansion The collaboration with Evonik to develop animal-free recombinant human serum albumin demonstrates the company's capability to partner with industry leaders, providing avenues to introduce innovative, animal-free bioproducts to clients focusing on ethical and sustainable manufacturing.

Customer Engagement Opportunities With a focus on bioinnovation and high-quality formulation services, InVitria's offerings are well-positioned to attract biotech companies seeking custom media, reagents, and manufacturing support to accelerate cell therapy development and commercialization.